• Bender, M. A., Viola, M. V., Fiore, J., Thompson, M. H. and Leonard, R. C., Normal G2 chromosomal radiosensitivity and cell survival in the cancer family syndrome. Cancer Res., 48, 25792584 (1988).
  • Boice, J. D., Harvey, E. B., Blettner, M., Stovall, M. and Flannery, J. T., Cancer in the contralateral breast after radiotherapy for breast cancer. N. Engl. J. Med., 326, 781785 (1992).
  • Claus, E. B., Risch, N. and Thompson, W. D., Age of onset as indicator of familial risk of breast cancer. Amer. J. Epidemiol., 131, 961972 (1990).
  • Cloos, J., Braakhuis, B. J., Steen, I., Copper, M. P., de Vries, N., Nauta, J. J. and Snow, G. B., Increased mutagen sensitivity in head-and-neck squamous cell carcinoma patients, particularly those with multiple primary tumors. Int. J. Cancer, 56, 816819 (1994).
  • Dave, B. J., Hsu, T. C., Hong, W. K. and Pathak, S., Nonrandom distribution of mutagen-induced chromosome breaks in lymphocytes of patients with different malignancies. Int. J. Oncol., 5, 733740 (1994).
  • Helzlsover, K. J., Harris, E. L., Parshad, R., Perry, H. R., Price, F. M. and Sanford, K. K., Familial clustering of breast cancer: possible interaction between DNA repair proficiency and radiation exposure in the development of breast cancer. Int. J. Cancer, 64, 1417 (1995).
  • Helzlsover, K. J., Harris, E. L., Parshad, R., Perry, H. R., Price, F. M. and Sanford, K. K., DNA repair proficiency: potential susceptibility factor for breast cancer. J. nat. Cancer Inst., 88, 754755 (1996).
  • Hoffman, D. A., Lonstein, J. E., Morin, M. M., Visscher, W., Harris, B. S. 3rd and Boice, J. D. Jr., Breast cancer in women with scoliosis exposed to multiple diagnostic X rays. J. nat. Cancer Inst., 81, 13071312 (1991).
  • Hsu, T. C., Johnston, D. A., Cherry, L. M., Ramkisoon, D., Schantz, S. P., Jessup, J. M., Winn, R. J., Shirley, L. and Furlong, C., Sensitivity to genotoxic effects of bleomycin in humans: possible relationship to environmental carcinogenesis. Int. J. Cancer, 43, 403409 (1989).
  • Knight, R. D., Parshad, R., Price, F. M., Tarone, R. E. and Sanford, K. K., X-ray-induced chromatid damage in relation to DNA repair and cancer incidence in family members. Int. J. Cancer, 54, 589593 (1993).
  • Kovacs, E. and Almendral, A., Reduced DNA repair synthesis in healthy women having first degree relatives with breast cancer. Europ. J. Cancer clin. Oncol., 23, 10511057 (1987).
  • Lavin, M. F., Bennett, I., Ramsay, J., Gardiner, R. A., Seymour, G. J., Farrell, A. and Walsh, M., Identification of a potentially radiosensitive subgroup among patients with breast cancer. J. nat. Cancer Inst., 86, 16271633 (1994).
  • Pandita, T. K. and Hittelman, W. N., Evidence for a chromatin basis for increased mutagen sensitivity associated with multiple primary malignancies of head and neck. Int. J. Cancer, 61, 738743 (1995).
  • Parshad, R., Price, F. M., Bohr, V. A., Cowans, K. H., Zujeweski, J. A. and Sanford, K. K., Deficient DNA repair capacity, a predisposing factor in breast cancer. Brit. J. Cancer, 74, 15 (1996).
  • Parshad, R., Sanford, K. K. and Jones, G. M., Chromatid damage after G2 phase X-irradiation of cells from cancer-prone individuals implicates deficiency in DNA repair. Proc. nat. Acad. Sci. (Wash.), 80, 56125616 (1983).
  • Parshad, R., Sanford, K. K. and Jones, G. M., Chromosomal radiosensitivity during the G2 cell cycle period of skin fibroblast from individuals with familial cancer. Proc. nat. Acad. Sci. (Wash.), 82, 54005403 (1985).
  • Pero, R. W., Johnson, D. B., Zang, E., Markowitz, M., Doyle, G. A., Lund-Pero, M., Seidegard, J., Halper, M. and Miller, D. G., DNA repair synthesis in individuals with and without family history of cancer. Carcinogenesis, 10, 693697 (1989).
  • Sanford, K. K., Parshad, R., Gantt, R. R. and Tarone, R. E., A deficiency in chromatin repair, genetic instability and predisposition to cancer. Crit. Rev. Oncol., 1, 323341 (1989).
  • Sanford, K. K., Parshad, R., Price, F. M., Jones, G. M., Tarone, R. E., Eierman, L., Hale, P. and Waldmann, T. A., Enhanced chromatin damage in blood lymphocytes after G2 phase X irradiation, a marker of the ataxia-telangiectasia gene. J. nat. Cancer Inst., 82, 10501054 (1990).
  • Sattin, R. W., Rubin, G., Webster, L. A., Huezo, C. M., Wingo, P. A., Ory, H. W. and Layde, P. M., Family history and risk of breast cancer. J. amer. med. Ass., 253, 19081913 (1985).
  • Swift, M., Reitnauer, P. J., Morrell, D. and Chase, C. L., Breast and other cancers in families with ataxia-telangiectasia. N. Engl. J. Med., 316, 12891294 (1987).
  • Vahakangas, K., Trivers, G. E., Plummer, S., Hayes, R. B., Krokan, H., Rowe, M., Swartz, R. P., Yeager, H. Jr. and Harris, C. C., O6-methylguanine-DNA methyltransferase and uracil DNA glycosylase in human bronchoalveolar lavage cells and peripheral blood mononuclear cells from tobacco smokers and non-smokers. Carcinogenesis, 12, 13891394 (1991).
  • Weichselbaum, R. R., Hallahan, D., Fuks, Z. and Kufe, D., Radiation induction of immediate early genes: effectors of the radiation-stress response. Int. J. Rad. Biol., 30, 229234 (1994).
  • West, C. M., Elyan, S. A., Berry, P., Cowan, R. and Scott, D., A comparison of the radiosensitivity of lymphocytes from normal donors, cancer patients, individuals with ataxia-telangiectasia (A-T) and A-T heterozygotes. Int. J. Rad. Biol., 68, 197203 (1995).
  • Who guide to short term tests for detecting mutagenic and carcinogenic chemicals. Environmental Health Criteria 51, PP. 5767, World Health Organization, Geneva (1985).